The research produced in the CQC originated the following spin-off companies:
|Luzitin is a pharmaceutical company focused on the investigation and development of innovative compounds for Photodynamic Therapy (PDT) or |
Photodiagnosis (PDx) of cancer and other diseases.
|LaserLeap Techologies provides a painless, safe and effective method to administer medicines and cosmetics through the skin. Additionally, skin recovers its protective function and pleasant look within one minute of the application of LaserLeap patented technology.|
BSIM2’s mission is to boost the discovery and optimisation of new drug candidates, led by efficient computational methodologies and workflows, focusing on neurodegenerative amyloid diseases